Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNEX Group Regulatory News (NXG)

  • There is currently no data for NXG

Form 8.3 - NEX GROUP PLC

30 Oct 2018 10:03

RNS Number : 7064F
Societe Generale SA
30 October 2018
Β 

FORM 8.3

Β 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Full name of discloser:

SociΓ©tΓ© GΓ©nΓ©rale S.A.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Β NEX Group Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

29/10/2018

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

YES: CME Group Inc

Β 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

Β 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Β 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Β 

Class of relevant security:

Β 

Ordinary

Β 

Β 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

9,065,584

2.39

25,128

0.01

(2) Cash-settled derivatives:

Β 

2,316,960

0.61

6,217,701

1.64

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0.00

0

0.00

Β 

TOTAL:

11,382,544

3.00

6,242,829

1.64

All interests and all short positions should be disclosed.

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental FormΒ 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors' and other employee options)

Β 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

Β 

-

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Β 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Β 

The currency of all prices and other monetary amounts should be stated.

Β 

(a) Purchases and sales

Β 

Class of relevant security

Purchase/sale

Number of securities

Price per unit GBP

Ordinary

Purchase

2,420

10.87

Ordinary

Purchase

801

10.87

Ordinary

Purchase

274

10.83

Ordinary

Purchase

113

10.87

Ordinary

Purchase

621

10.87

Ordinary

Purchase

240

10.84

Ordinary

Purchase

236

10.86

Ordinary

Purchase

734

10.88

Ordinary

Purchase

735

10.88

Ordinary

Purchase

232

10.9

Ordinary

Purchase

539

10.87

Ordinary

Purchase

772

10.9

Ordinary

Purchase

488

10.9

Ordinary

Purchase

493

10.9

Ordinary

Purchase

393

10.9

Ordinary

Purchase

611

10.89

Ordinary

Sale

78

10.94

Ordinary

Sale

209

10.94

Ordinary

Sale

599

10.94

Ordinary

Sale

334

10.94

Ordinary

Sale

766

10.91

Ordinary

Sale

1,027

10.93

Ordinary

Sale

183

10.93

Ordinary

Sale

812

10.93

Ordinary

Sale

1,104

10.94

Ordinary

Sale

1,120

10.93

Ordinary

Sale

143

10.93

Ordinary

Sale

995

10.93

Ordinary

Sale

735

10.9

Ordinary

Sale

1,113

10.92

Ordinary

Sale

158

10.92

Ordinary

Sale

1,007

10.92

Ordinary

Sale

860

10.92

Ordinary

Sale

1,128

10.95

Ordinary

Sale

3

10.89

Total Purchases

9,702

Total Sales

12,374

Β 

(b) Cash-settled derivative transactions

Β 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit GBP

Β 

(c) Stock-settled derivative transactions (including options)

Β 

(i) Writing, selling, purchasing or varying

Β 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit GBP

Β 

(ii) Exercise

Β 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit GBP

Β 

Β 

Β 

(d) Other dealings (including subscribing for new securities)

Β 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable) GBP

Β 

Β 

Β 

4. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

Β 

Β 

Β 

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Β 

Β 

Β 

Β 

(c) Attachments

Β 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Β 

Β 

Date of disclosure:

30/10/2018

Contact name:

Olivier Vero

Telephone number:

+44 20 7676 6969

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

Β 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
RETFDSFSSFASESS
Date   Source Headline
21st Sep 20183:00 pmBUSForm 8.3 - NEX Group Plc
21st Sep 20182:56 pmRNSForm 8.3 - [NEX Group PLC]
21st Sep 20182:40 pmRNSForm 8.3 - CME Group Inc
21st Sep 20182:29 pmRNSForm 8.3 - NEX Group plc
21st Sep 20182:17 pmRNSForm 8.3 - CME Group Inc.
21st Sep 20182:17 pmRNSForm 8.3 - NEX Group Plc
21st Sep 20181:23 pmRNSForm 8.3 - CME GROUP INC
21st Sep 201812:56 pmRNSForm 8.3 - NEX Group plc
21st Sep 201812:35 pmRNSForm 8.3 - NEX Group PLC
21st Sep 201811:47 amBUSForm 8.5 (EPT/NON-RI) - NEX GROUP PLC
21st Sep 201811:43 amRNSForm 8.3 - CME Group Inc.
21st Sep 201811:41 amRNSForm 8.5 (EPT/RI)
21st Sep 201811:40 amRNSForm 8.5 (EPT/RI)
21st Sep 201811:33 amRNSForm 8.5 (EPT/RI) - NEX Group plc
21st Sep 201811:04 amRNSForm 8.5 (EPT/RI)
21st Sep 201810:20 amRNSForm 8.3 - CME Group Inc. (Replacement)
20th Sep 20184:45 pmRNSForm 8.5 (EPT/RI) - Amendment
20th Sep 20183:30 pmRNSForm 8.3 -NEX Group
20th Sep 20183:25 pmBUSForm 8.3 - Nex Group plc
20th Sep 20183:21 pmRNSForm 8.3 - CME Group Inc
20th Sep 20183:20 pmRNSForm 8.3 - NEX Group plc
20th Sep 20183:01 pmRNSForm 8.3 - Nex Group Plc
20th Sep 20182:54 pmRNSForm 8.3 - CME GROUP INC
20th Sep 20182:52 pmRNSForm 8.3 - NEX Group plc
20th Sep 20182:49 pmRNSForm 8.3 - CME Group Inc
20th Sep 20182:38 pmRNSForm 8.3 - NEX Group PLC
20th Sep 20182:32 pmRNSForm 8.3 - CME Group Inc.
20th Sep 20182:27 pmRNSForm 8.3 - NEX Group Plc
20th Sep 201812:50 pmRNSForm 8.3 - CME Group Inc
20th Sep 201812:45 pmBUSFORM 8.5 (EPT/NON-RI) - NEX GROUP PLC
20th Sep 201811:32 amRNSForm 8.5 (EPT/RI)
20th Sep 201811:25 amRNSForm 8.3 - NEX Group plc
20th Sep 201811:06 amRNSForm 8.5 (EPT/RI)
20th Sep 201810:43 amRNSForm 8.5 (EPT/RI)
20th Sep 201810:41 amRNSForm 8.5 (EPT/RI) - NEX Group plc
20th Sep 20189:40 amRNSForm 8.3 - NEX Group Plc
20th Sep 20189:38 amBUSForm 8.5 (EPT/NON-RI) - NEX GROUP PLC
19th Sep 20184:35 pmRNSForm 8.3 - CME Group Inc
19th Sep 20183:56 pmRNSForm 8.3 - CME GROUP INC
19th Sep 20183:20 pmRNSForm 8.3 - NEX Group plc
19th Sep 20182:46 pmRNSForm 8.3 - CME Group Inc.
19th Sep 20182:32 pmRNSForm 8.3 - CME Group Inc.
19th Sep 20182:31 pmRNSForm 8.5 (EPT/RI)- NEX Group plc AMENDMENT
19th Sep 20182:30 pmRNSForm 8.3 - CME Group Inc
19th Sep 20182:28 pmRNSForm 8.5 (EPT/RI)- NEX Group plc AMENDMENT
19th Sep 20181:53 pmRNSForm 8.3 - CME Group Inc.
19th Sep 20181:53 pmRNSForm 8.3 - NEX Group Plc
19th Sep 20181:15 pmRNSForm 8.3 - CME Group
19th Sep 201812:24 pmRNSForm 8.3 - NEX Group plc
19th Sep 201811:48 amBUSForm 8.5 (EPT/NON-RI) - NEX GROUP PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.